Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2010
12/09/2010US20100310660 Dry powder microparticles for pulmonary delivery
12/09/2010US20100310658 Electroprocessed Fibrin-Based Matrices and Tissues
12/09/2010US20100310654 Homeopathic remedies for use before and after aesthetic injectable and surgical procedures to minimize swelling and bruising
12/09/2010US20100310649 Solid lipid microcapsules containing growth hormone inner core microparticles
12/09/2010US20100310644 Anti-dandruff compositions containing peptides
12/09/2010US20100310640 Hla-dr binding peptides and their uses
12/09/2010US20100310637 Composition and method for the treatment or prevention of glaucoma and ocular hypertension
12/09/2010US20100310636 Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof
12/09/2010US20100310635 Compositions and Methods for Regulating T-Cell Activity
12/09/2010US20100310633 Chitinosanase
12/09/2010US20100310631 Filament based on hyaluronic acid in the form of free acid and method for obtaining it
12/09/2010US20100310626 Erythropoietin and fibronectin compositions for bone regeneration
12/09/2010US20100310623 Synergetic functionalized spiral-in-tubular bone scaffolds
12/09/2010US20100310622 Dry eye treatment by puncta plugs
12/09/2010US20100310612 Medicament for the Treatment of Cancer of the Pancreas
12/09/2010US20100310603 TEM8 as an Adjuvant and Uses Thereof
12/09/2010US20100310594 Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens
12/09/2010US20100310593 Vaccines Against Chlamydia Infection
12/09/2010US20100310592 A truncated form of the hiv p17 protein
12/09/2010US20100310583 Let-7 microrna and mimetics thereof as therapeutics for cancer
12/09/2010US20100310580 Compositions and methods for treating pruritus
12/09/2010US20100310579 Method for inhibiting angiogenesis or for treatment of cancer
12/09/2010US20100310577 Methods for increasing thermogenic adipocytes
12/09/2010US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
12/09/2010US20100310575 Inhibitors of Caspase I-Dependent Cytokines in the Treatment of Neurodegenerative Disorders
12/09/2010US20100310574 Methods and compositions for the treatment and diagnosis of statin-induced myopathy
12/09/2010US20100310569 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae
12/09/2010US20100310568 Ninjurin-1 modulation and uses thereof
12/09/2010US20100310560 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
12/09/2010US20100310555 Compositions with hematopoietic and immune activity
12/09/2010US20100310553 Compositions and Methods for Controlling Hepatitis C Virus Infection
12/09/2010US20100310550 Alpha 1- antitrypsin compositions
12/09/2010US20100310549 Inhibitors of type 2 vascular endothelial growth factor receptors
12/09/2010US20100310547 Treatment of Inflammatory Diseases
12/09/2010US20100310546 ACE2 Polypeptide
12/09/2010US20100310545 Dry treatment mixture and methods of production and use
12/09/2010US20100310544 Composition comprising calcium ions and at least one proteolytic enzyme for use in the in vitro and in vivo regeneration of cutaneous and connective tissues
12/09/2010US20100310543 Method of preventing and treating acute brain pathologies
12/09/2010US20100310542 Pharmaceutical Compositions for treating wouds and related methods
12/09/2010US20100310541 Compositions and Methods for Reducing the Toxicity of Certain Toxins
12/09/2010US20100310540 Methods of screening for compounds that modulate tafia activity, compounds, and methods of using the compounds
12/09/2010US20100310539 Method for manufacturing mesoporous materials, materials so produced and use of mesoporous materials
12/09/2010US20100310532 Gene targets in anti-aging therapy and tissue repair
12/09/2010US20100310528 Vector System for Site-Specific Integration
12/09/2010US20100310524 Compositions Suitable for Treatment of Spinal Disease, Disorder or Condition
12/09/2010US20100310522 Novel Polypeptides Having Endolysin Activity and Uses Thereof
12/09/2010US20100310516 Duplexed Parvovirus Vectors
12/09/2010US20100310515 Latency Associated Protein Construct With Aggrecanase Sensitive Cleavage Site
12/09/2010US20100310512 Antiviral compounds
12/09/2010US20100310511 Determining disease or immune system features based on analysis of immune system characteristics
12/09/2010US20100310510 N-terminally chemically modified protein compositions and methods
12/09/2010US20100310509 COMPOSITIONS COMPRISING MODULATORS OF SIGNAL TRANSDUCING RECEPTOR gp130 AND METHODS OF PRODUCING AND USING SAME
12/09/2010US20100310508 METHODS OF TREATMENT INVOLVING p21/CIP1
12/09/2010US20100310507 Use of 2 anti-sparc antibodies to predict response to chemotherapy
12/09/2010US20100310506 Immunoconjugates for the Treatment of Tumours
12/09/2010US20100310505 Methods of treating cancer using il-21
12/09/2010US20100310504 Methods for treating fibrosis by modulating cellular senescence
12/09/2010US20100310503 Novel compositions and methods for cancer treatment
12/09/2010US20100310502 Method of treating local infections in mammals
12/09/2010US20100310501 Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian Subject
12/09/2010US20100310500 Alkanoylamino benzamide aniline hdac inhibitor compounds
12/09/2010US20100310493 Acetamide derivatives as glucokinase activators, their process and medicinal application
12/09/2010US20100310484 Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
12/09/2010US20100310472 Dna sequence, and recombinant preparation of the grass pollen allergen lol p 4
12/09/2010US20100310470 Immunomodulatory polymeric antigens for treating inflammatory pathologies
12/09/2010US20100310469 Vaccine immunotherapy for immune suppressed patients
12/09/2010US20100310458 Use of soluble ceacam8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis
12/09/2010US20100310455 Heterocyclic Ligands for Integrin Imaging and Therapy
12/09/2010US20100310454 Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and /or their cancerous counterpart
12/09/2010DE102009024133A1 Bacterial nanocellulose, useful e.g. for cartilage regeneration, comprises a structure consisting of a wide-meshed phase of bacterial nanocellulose and a close-meshed phase of bacterial nanocellulose firmly connected with wide-meshed phase
12/09/2010CA2764499A1 Interlaced method for treating cancer or a precancerous condition
12/09/2010CA2764490A1 Antimicrobial peptides
12/09/2010CA2764461A1 Serum amyloid p derivatives and their preparation and use
12/09/2010CA2764454A1 Improved reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c)
12/09/2010CA2764351A1 Stimulator of genital, sexual, and reproductive function
12/09/2010CA2764327A1 Ophthalmic oil-in-water emulsions containing cyclosporine or a polyphenol
12/09/2010CA2764326A1 Therapeutic ophthalmic emulsions
12/09/2010CA2764164A1 Immunoregulatory peptides and methods of use
12/09/2010CA2764029A1 Method for enhancing phagocytosis of phosphatidylserine-exposing cells
12/09/2010CA2763977A1 Human milk peptides
12/09/2010CA2763918A1 Soga polynucleotides and polypeptides and uses thereof
12/09/2010CA2763838A1 Immunologic tests and kits
12/09/2010CA2763749A1 Synthesis and use of radiolabelled insulin analogues
12/09/2010CA2763626A1 Recombinant production of peptides
12/09/2010CA2763529A1 Compositions and methods modulating mg29 for the treatment of diabetes
12/09/2010CA2763492A1 Biomaterials, compositions, and methods
12/09/2010CA2763164A1 Methods of modulating fucosylation of glycoproteins
12/09/2010CA2762342A1 Method for cancer therapy based on co-administration of a parvovirus and a cytokine
12/09/2010CA2761854A1 Pharmaceutical compositions containing antifungal peptides
12/09/2010CA2760655A1 Heterocyclic compounds and expansion agents for hematopoietic stem cells
12/08/2010EP2258869A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258868A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258867A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
12/08/2010EP2258849A1 Mammalian receptor proteins; related reagents and methods
12/08/2010EP2258848A1 Il-17 homologous polypeptide and therapeutic uses thereof
12/08/2010EP2258847A2 Futher novel forms of interfering RNA molecules
12/08/2010EP2258842A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/08/2010EP2258841A1 Methods for treating pain
12/08/2010EP2258834A1 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
12/08/2010EP2258726A1 High affinity human antibodies to c-erbB-2
1 ... 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 ... 3163